Full-Time

Software Engineer – Senior / Staff / Principal

Confirmed live in the last 24 hours

Genesis Therapeutics

Genesis Therapeutics

51-200 employees

AI-driven drug discovery for pharmaceuticals

AI & Machine Learning
Biotechnology

Senior, Expert

Burlingame, CA, USA

Hybrid position requiring in-office presence.

Category
Backend Engineering
Full-Stack Engineering
Software Engineering
Requirements
  • A deep thinker who reasons from first principles, balances attention to detail with architectural thinking, and has an investigational curiosity to find the root cause of a problem
  • Comfortable working across all levels of the software stack, from front-end interfaces to backend features to managing infrastructure
  • Experienced writing production code and driving projects to completion
  • Interested in learning more about drug discovery and machine learning
Responsibilities
  • Build and expand on tools for visualizing molecules and proteins, analyzing machine learning models, and managing complex chemical workflows
  • Work closely with machine learning engineers and medicinal chemists to develop and productionize new computational methods for molecular property prediction
  • Help scale our data infrastructure to handle billions of datapoints and thousands of parallel deep learning and molecular dynamics jobs

Genesis Therapeutics uses artificial intelligence to accelerate the development of new medicines in the pharmaceutical industry. By employing 3D spatial graph modeling and advanced molecular simulation, the company identifies potential drug candidates and explores new chemical spaces. Unlike its competitors, Genesis Therapeutics focuses on strategic partnerships with other biotech firms, such as Eli Lilly, to generate revenue through upfront payments and future earnings based on drug success. The company's goal is to discover new medicines that address unmet medical needs.

Company Stage

Series B

Total Funding

$272.5M

Headquarters

Burlingame, California

Founded

2019

Growth & Insights
Headcount

6 month growth

14%

1 year growth

45%

2 year growth

137%
Simplify Jobs

Simplify's Take

What believers are saying

  • Partnership with NVIDIA enhances GEMS platform for targeting diseases with high unmet needs.
  • Recognition as a 'Fierce 15' company underscores Genesis' innovative approach in drug development.
  • Recent $224M equity investment indicates strong investor confidence in Genesis' AI platform.

What critics are saying

  • Increased competition from AI-driven drug discovery companies like Insilico Medicine and Exscientia.
  • Over-reliance on partnerships could lead to financial instability if drugs aren't successful.
  • Rapid AI advancements may require costly updates to maintain competitive advantage.

What makes Genesis Therapeutics unique

  • Genesis Therapeutics uses AI to accelerate drug discovery with 3D spatial graph modeling.
  • The GEMS platform integrates deep learning, molecular simulations, and generative AI for drug design.
  • Strategic partnerships with Eli Lilly and Gilead highlight Genesis' industry collaboration strength.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Competitive salary

Equity

Medical, dental, & vision insurance

401(k) program